Clinical Trial Update: Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis

View source ↗

Summary

Completed real-world study assessing the health economic outcomes of Betaseron in relapsing forms of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• Betaseron (Interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis, Relapsing-Remitting | Status: COMPLETED